The Advanced Wound Care Matrix Exempt From CMS Pricing Cap

On October 31, 2025, the Centers for Medicare & Medicaid Services (CMS) finalized the CY 2026 Physician Fee Schedule (PFS), introducing a standardized reimbursement rate of $127.28 per square centimeter for most advanced skin substitute products, effective January 1, 2026.

While this policy was designed to regulate reimbursement, it presents significant challenges for manufacturers, clinics, and (most importantly) patients. By applying a uniform price across products that vary widely in clinical design, performance, and cost, many providers may face reduced access to critical wound care therapies and limited treatment flexibility.

At Wound Care Portal and our parent company, RegenEdge Ventures, our mission is rooted in patient outcomes and long-term healing success. Like many leaders in wound care, we are deeply concerned about how these changes may restrict provider choice and innovation at the very moment patients need advanced therapies most.

OCM™ Stands Apart from the CMS Pricing Mandate

Amid these sweeping reimbursement changes, Omeza Complete Matrix (OCM™) remains an exception for advanced wound care solutions. CMS has determined that non-sheet products, including OCM™, will continue to be carrier-priced by local Medicare Administrative Contractors (MACs) and are exempt from the $127.28 per cm² pricing cap.

OCM™ maintains its established reimbursement of $2,050 per vial across all major jurisdictions, with MACs either honoring published local rates or reimbursing based on invoice pricing. This distinction positions OCM™ as one of the few advanced wound care technologies not impacted by the new CMS reimbursement restrictions, providing clinics with both financial stability and continued access to a proven therapy.

Omeza™ is a malleable solid that fits in any wound

A Strategic Opportunity for Forward-Thinking Wound Care Clinics

RegenEdge Ventures is proud of our partnership with Omeza, delivering OCM™ to providers and clinics nationwide. As an organization focused on longevity, innovation, and clinical excellence, we are building partnerships that will define the next era of wound healing.

Now is the time for clinics to protect their protocols from reimbursement disruption while strengthening patient outcomes with a clinically supported, operationally efficient wound care solution. OCM™ offers providers a rare opportunity:

• Consistent reimbursement

• Regulatory protection from new pricing caps

• Strong clinical performance

• Long-term operational sustainability
  
  

Bring OCM™ to Your Wound Care Protocol

If you are evaluating how the CMS 2026 changes will impact your practice, this is the moment to act. Securing access to OCM™ now ensures your clinic remains equipped with an advanced therapy that is both financially viable and clinically powerful in the new reimbursement environment.

For more information about Omeza OCM™ or to begin offering it at your clinic, contact us today:

Email: admin@regenedgesummit.com
Phone: 203-715-8390

Wound Care Portal and RegenEdge Ventures are committed to helping clinics navigate regulatory change while continuing to deliver the highest standard of patient care.